{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:42:07Z","timestamp":1785516127943,"version":"3.56.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Landesgraduiertenf\u00f6rderung Programme of the State of Baden-W\u00fcrttemberg, Germany"},{"DOI":"10.13039\/501100018936","name":"Universit\u00e4tsklinikum Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018936","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s40266-023-01089-3","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T15:03:45Z","timestamp":1707231825000},"page":"153-164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development and Pilot Testing of an Algorithm-Based Approach to Anticholinergic Deprescribing in Older Patients"],"prefix":"10.1007","volume":"41","author":[{"given":"Tanja","family":"Wehran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Eidam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Czock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Kopitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstanze","family":"Plaschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete","family":"Mattern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter Emil","family":"Haefeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen Martin","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1215-634X","authenticated-orcid":false,"given":"Hanna Marita","family":"Seidling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"1089_CR1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","volume":"168","author":"JL Rudolph","year":"2008","unstructured":"Rudolph JL, Salow MJ, Angelini MC, et al. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Int Med. 2008;168:508\u201313.","journal-title":"Arch Int Med"},{"key":"1089_CR2","first-page":"401","volume":"175","author":"SL Gray","year":"2015","unstructured":"Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA. 2015;175:401\u20137.","journal-title":"JAMA"},{"key":"1089_CR3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40266-014-0158-4","volume":"31","author":"MS Salahudeen","year":"2014","unstructured":"Salahudeen MS, Duffull SB, Nishtala PS. Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review. Drugs Aging. 2014;31:185\u201392.","journal-title":"Drugs Aging"},{"key":"1089_CR4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jagp.2017.08.005","volume":"26","author":"Y Jaidi","year":"2018","unstructured":"Jaidi Y, Nonnonhou V, Kanagaratnam L, et al. Reduction of the anticholinergic load makes it possible to decrease behavioral and psychological symptoms of dementia. Am J Geriatr Psychiatry. 2018;26:280\u20138.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1089_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004850-200401000-00005","volume":"19","author":"T Drimer","year":"2004","unstructured":"Drimer T, Shahal B, Barak Y. Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients. Int Clin Psychopharmacol. 2004;19:27\u20139.","journal-title":"Int Clin Psychopharmacol"},{"key":"1089_CR6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/gerona\/gls176","volume":"68","author":"H Kersten","year":"2013","unstructured":"Kersten H, Molden E, Tolo IK, et al. Cognitive effects of reducing anticholinergic drug load in a frail elderly population: a randomized controlled trial. J Gerontol. 2013;68:271\u20138.","journal-title":"J Gerontol"},{"key":"1089_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40266-013-0063-2","volume":"30","author":"P Lampela","year":"2013","unstructured":"Lampela P, Lavikainen P, Garcia-Horsman JA, et al. Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study. Drugs Aging. 2013;30:321\u201330.","journal-title":"Drugs Aging"},{"key":"1089_CR8","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1345\/aph.1P310","volume":"44","author":"D Gnjidic","year":"2010","unstructured":"Gnjidic D, Le Couteur DG, Abernethy DR, et al. A pilot randomized clinical trial utilizing the drug load index to reduce exposure to anticholinergic and sedative medications in older people. Ann Pharmacother. 2010;44:1725\u201332.","journal-title":"Ann Pharmacother"},{"key":"1089_CR9","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00228-013-1499-3","volume":"69","author":"CE Duran","year":"2013","unstructured":"Duran CE, Azermai M, Vander Stichele RH. Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol. 2013;69:1485\u201396.","journal-title":"Eur J Clin Pharmacol"},{"key":"1089_CR10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/bcpt.12699","volume":"120","author":"TT Klamer","year":"2017","unstructured":"Klamer TT, Wauters M, Azermai M, et al. A novel scale linking potency and dosage to estimate anticholinergic exposure in older adults: the Muscarinic Acetylcholinergic Receptor ANTagonist Exposure Scale. Bas Clin Pharmacol Toxicol. 2017;120:582\u201390.","journal-title":"Bas Clin Pharmacol Toxicol"},{"key":"1089_CR11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12877-018-0929-6","volume":"18","author":"EK Kiesel","year":"2018","unstructured":"Kiesel EK, Hopf YM, Drey M. An anticholinergic load score for German prescribers: score development. BMC Geriatr. 2018;18:239.","journal-title":"BMC Geriatr"},{"key":"1089_CR12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jagp.2017.01.009","volume":"25","author":"T Mayer","year":"2017","unstructured":"Mayer T, Meid AD, Saum KU, et al. Comparison of nine instruments to calculate anticholinergic load in a large cohort of older outpatients: association with cognitive and functional decline, falls, and use of laxatives. Am J Geriatr Psychiatry. 2017;25:531\u201340.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1089_CR13","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1089\/10665270260518317","volume":"9","author":"S Doniger","year":"2002","unstructured":"Doniger S, Hofmann T, Yeh J. Predicting CNS permeability of drug molecules: comparison of neural network and support vector machine algorithms. J Comput Biol. 2002;9:849\u201364.","journal-title":"J Comput Biol"},{"key":"1089_CR14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00228-016-2162-6","volume":"73","author":"H Wouters","year":"2017","unstructured":"Wouters H, van der Meer H, Taxis K. Quantification of anticholinergic and sedative drug load with the Drug Load Index: a review of outcomes and methodological quality of studies. Eur J Clin Pharmacol. 2017;73:257\u201366.","journal-title":"Eur J Clin Pharmacol"},{"key":"1089_CR15","doi-asserted-by":"crossref","unstructured":"Petermann F, J\u00e4ncke L, Waldmann H-C. NAB Neuropsychological Assessment Battery. 2016. https:\/\/www.testzentrale.de\/shop\/neuropsychological-assessment-battery.html. Accessed 27 Oct 2017.","DOI":"10.1024\/1016-264X\/a000181"},{"issue":"4","key":"1089_CR16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3111\/13696990903430481","volume":"12","author":"AM Rentz","year":"2009","unstructured":"Rentz AM, Yu R, Muller-Lissner S, Leyendecker P. Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation. J Med Econ. 2009;12(4):371\u201383.","journal-title":"J Med Econ"},{"issue":"2","key":"1089_CR17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000474438","volume":"31","author":"X Badia","year":"1997","unstructured":"Badia X, Garcia-Losa M, Dal-Re R. Ten-language translation and harmonization of the International Prostate Symptom Score: developing a methodology for multinational clinical trials. Eur Urol. 1997;31(2):129\u201340.","journal-title":"Eur Urol"},{"issue":"2","key":"1089_CR18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00391-015-0968-y","volume":"50","author":"G Herrmann","year":"2017","unstructured":"Herrmann G, Muller K, Behr M, Hahnel S. Xerostomia and its impact on oral health-related quality of life. Z Gerontol Geriatr. 2017;50(2):145\u201350.","journal-title":"Z Gerontol Geriatr"},{"issue":"3","key":"1089_CR19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1079-2104(97)90341-3","volume":"84","author":"H Pajukoski","year":"1997","unstructured":"Pajukoski H, Meurman JH, Snellman-Grohn S, Keinanen S, Sulkava R. Salivary flow and composition in elderly patients referred to an acute care geriatric ward. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84(3):265\u201371.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"3","key":"1089_CR20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archpsyc.1980.01780160063007","volume":"37","author":"L Tune","year":"1980","unstructured":"Tune L, Coyle JT. Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Arch Gen Psychiatry. 1980;37(3):293\u20137.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"1089_CR21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jpainsymman.2016.05.015","volume":"52","author":"K Plaschke","year":"2016","unstructured":"Plaschke K, Petersen KA, Frankenhauser S, Weigand MA, Kopitz J, Bardenheuer HJ. The impact of plasma cholinergic enzyme activity and other risk factors for the development of delirium in patients receiving palliative care. J Pain Symptom Manage. 2016;52(4):525\u201332.","journal-title":"J Pain Symptom Manage"},{"key":"1089_CR22","unstructured":"Memory Clinic des Universit\u00e4tsspitals Basel, Schweiz. Die Neuropsychologische Testbatterie CERAD-Plus. https:\/\/www.memoryclinic.ch\/de\/main-navigation\/neuropsychologen\/cerad-plus\/. Accessed 27 Oct 2017."},{"key":"1089_CR23","unstructured":"Oswald WD, Fleischmann UM. N\u00fcrnberger-Alters-Inventar (NAI). 4. Aufl. 1997. https:\/\/www.testzentrale.de\/shop\/das-nuernberger-alters-inventar.html. Accessed 27 Oct 2017."},{"key":"1089_CR24","unstructured":"Ihl R, Weyer G. Alzheimer's Disease Assessment Scale. 1993. https:\/\/www.testzentrale.de\/shop\/alzheimer-s-disease-assessment-scale.html. Accessed 27 Oct 2017."},{"issue":"4","key":"1089_CR25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"1089_CR26","unstructured":"Folstein ME, Folstein SE, White T, Messer MA. Mini-Mental-Status-Test: 2. Ausgabe. 2010. https:\/\/www.testzentrale.de\/shop\/mini-mentalr-state-examination-2nd-editiontm.html. Accessed 27 Oct 2017."},{"key":"1089_CR27","unstructured":"Stemmler M, Lehfeld H, Horn R. SKT nach Erzigkeit. 2015. https:\/\/www.testzentrale.de\/shop\/kurztest-zur-erfassung-von-gedaechtnis-und-aufmerksamkeitsstoerungen.html. Accessed 27 Oct 2017."},{"key":"1089_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psych Res. 1975;12:189\u201398.","journal-title":"J Psych Res"},{"key":"1089_CR29","doi-asserted-by":"crossref","first-page":"e2295","DOI":"10.1212\/WNL.0000000000010643","volume":"95","author":"AJ Weigand","year":"2020","unstructured":"Weigand AJ, Bondi MW, Thomas KR, et al. Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults. Neurology. 2020;95:e2295\u2013304.","journal-title":"Neurology"},{"key":"1089_CR30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/phar.2106","volume":"38","author":"NL Campbell","year":"2018","unstructured":"Campbell NL, Lane KA, Gao S, et al. Anticholinergics influence transition from normal cognition to mild cognitive impairment in older adults in primary care. Pharmacotherapy. 2018;38:511\u20139.","journal-title":"Pharmacotherapy"},{"key":"1089_CR31","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","volume":"179","author":"CAC Coupland","year":"2019","unstructured":"Coupland CAC, Hill T, Dening T, et al. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Intern Med. 2019;179:1084\u201393.","journal-title":"JAMA Intern Med"},{"key":"1089_CR32","first-page":"80","volume":"33","author":"AM Lupu","year":"2021","unstructured":"Lupu AM, MacCamy KL, Gannon JM, et al. Less is more: deprescribing anticholinergic medications in persons with severe mental illness. Ann Clin Psychiatry. 2021;33:80\u201392.","journal-title":"Ann Clin Psychiatry"},{"key":"1089_CR33","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/ggi.12000","volume":"13","author":"YC Yeh","year":"2013","unstructured":"Yeh YC, Liu CL, Peng LN, et al. Potential benefits of reducing medication-related anticholinergic load for demented older adults: a prospective cohort study. Geriatr Gerontol Int. 2013;13:694\u2013700.","journal-title":"Geriatr Gerontol Int"},{"key":"1089_CR34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11096-019-00784-9","volume":"41","author":"N Ailabouni","year":"2019","unstructured":"Ailabouni N, Mangin D, Nishtala PS. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. Int J Clin Pharm. 2019;41:167\u201378.","journal-title":"Int J Clin Pharm"},{"key":"1089_CR35","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/ageing\/afaa072","volume":"49","author":"D O'Mahony","year":"2020","unstructured":"O\u2019Mahony D, Gudmundsson A, Soiza RL, et al. Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial. Age Ageing. 2020;49:605\u201314.","journal-title":"Age Ageing"},{"key":"1089_CR36","volume":"12","author":"Y Cunningham","year":"2021","unstructured":"Cunningham Y, Wood K, Stewart C, et al. Understanding stakeholder views regarding the design of an intervention trial to reduce anticholinergic burden: a qualitative study. Front Pharmacol. 2021;12: 608208.","journal-title":"Front Pharmacol"},{"key":"1089_CR37","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1111\/jgs.17965","volume":"70","author":"M Ha","year":"2022","unstructured":"Ha M, Furman A, Al Rihani SB, et al. Pharmacist-driven interventions to de-escalate urinary antimuscarinics in the Programs of All-Inclusive Care for the Elderly. J Am Geriatr Soc. 2022;70:3230\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"1089_CR38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/1060028016652997","volume":"50","author":"L Kouladjian","year":"2016","unstructured":"Kouladjian L, Gnjidic D, Reeve E, et al. Health care practitioners\u2019 perspectives on deprescribing anticholinergic and sedative medications in older adults. Ann Pharmacother. 2016;50:625\u201336.","journal-title":"Ann Pharmacother"},{"key":"1089_CR39","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jamainternmed.2019.0676","volume":"179","author":"NL Campbell","year":"2019","unstructured":"Campbell NL, Holden R, Boustani MA. Preventing Alzheimer disease by deprescribing anticholinergic medications. JAMA Intern Med. 2019;179:1093\u20134.","journal-title":"JAMA Intern Med"},{"key":"1089_CR40","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/459013","volume":"2014","author":"K Hori","year":"2014","unstructured":"Hori K, Konishi K, Tani M. Serum anticholinergic activity: a possible peripheral marker of the anticholinergic load in the central nervous system in Alzheimer\u2019s disease. Dis Markers. 2014;2014: 459013.","journal-title":"Dis Markers"},{"key":"1089_CR41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00002512-199915010-00002","volume":"15","author":"AR Moore","year":"1999","unstructured":"Moore AR, O\u2019Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging. 1999;15:15\u201328.","journal-title":"Drugs Aging"},{"key":"1089_CR42","first-page":"A261","volume":"103","author":"PG Lankisch","year":"2006","unstructured":"Lankisch PG, Mahlke R, L\u00fcbbers H, et al. Leitsymptom Diarrh\u00f6. Deutsches \u00c4rzteblatt. 2006;103:A261\u20139.","journal-title":"Deutsches \u00c4rzteblatt"},{"key":"1089_CR43","unstructured":"Gemeinsame Leitlinie der DGNM und der DGVS. S2k-Leitlinie Chronische Obstipation: Definition, Pathophysiologie, Diagnostik und Therapie (Aktueller Stand: 10\/2021). https:\/\/register.awmf.org\/assets\/guidelines\/021-019l_S2k_Chronische_Obstipation_2022-11.pdf. Accessed 31 Dec 2022."},{"key":"1089_CR44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00002018-199819010-00004","volume":"19","author":"MJ Drake","year":"1998","unstructured":"Drake MJ, Nixon PM, Crew JP. Drug-induced bladder and urinary disorders. Incidence, prevention and management. Drug Saf. 1998;19:45\u201355.","journal-title":"Drug Saf"},{"key":"1089_CR45","doi-asserted-by":"crossref","first-page":"811","DOI":"10.7150\/ijms.12912","volume":"12","author":"J Miranda-Rius","year":"2015","unstructured":"Miranda-Rius J, Brunet-Llobet L, Lahor-Soler E, et al. Salivary secretory disorders, inducing drugs, and clinical management. Int J Med Sci. 2015;12:811\u201324.","journal-title":"Int J Med Sci"},{"key":"1089_CR46","first-page":"245","volume":"35","author":"D Strobach","year":"2012","unstructured":"Strobach D. Clinically significant drug-drug interactions between analgesics and psychotopics [in German]. Med Monatschrift Pharm. 2012;35:245\u201354 (quiz 55\u20136).","journal-title":"Med Monatschrift Pharm"},{"key":"1089_CR47","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/jpm.2006.0112","volume":"10","author":"C White","year":"2007","unstructured":"White C, McCann MA, Jackson N. First do no harm\u2026 Terminal restlessness or drug-induced delirium. J Pall Med. 2007;10:345\u201351.","journal-title":"J Pall Med"},{"key":"1089_CR48","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/CIA.S1847","volume":"3","author":"DL Chau","year":"2008","unstructured":"Chau DL, Walker V, Pai L, Cho LM. Opiates and elderly: use and side effects. Clin Intervent Aging. 2008;3:273\u20138.","journal-title":"Clin Intervent Aging"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01089-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-023-01089-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01089-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T13:10:50Z","timestamp":1708002650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-023-01089-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1089"],"URL":"https:\/\/doi.org\/10.1007\/s40266-023-01089-3","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"29 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open Access funding enabled and organized by Projekt DEAL.TW received a personal scholarship from the Landesgraduiertenf\u00f6rderung Programme of the State of Baden-W\u00fcrttemberg, Germany, awarded by the Graduate Academy of Heidelberg University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Tanja Wehran, Annette Eidam, David Czock, J\u00fcrgen Kopitz, Konstanze Plaschke, Margarete Mattern, Walter Emil Haefeli, J\u00fcrgen Martin Bauer, and Hanna Marita Seidling filled in an International Committee of Medical Journal Editors (ICMJE) statement and declare that there are no conflicts of interest with regard to this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Data is not publicly available because this potential use case was not included in the patient's and physician\u2019s informed consent forms. Patients (as well as physicians) agreed to the use of their data in the context of the study but were not informed and did not agree upon their data being publicly available. However, data are available in anonymized form upon reasonable request at klinische.pharmakologie@med.uni-heidelberg.de.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data"}},{"value":"The study was approved by the responsible Ethics Committee of the Medical Faculty of Heidelberg University (protocol # S-116\/2017), registered in the German Clinical Trials Register (#DRKS00012346), and was planned and conducted in accordance with the current version of the Declaration of Helsinki.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and trial registration"}},{"value":"All participants (physicians and patients) provided written informed consent.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"The authors contributed to this paper as follows. Study design: All authors. Development of the anticholinergic drug list, algorithms, and test battery: TW, WEH, DC, MM, HMS, AE, JMB. Development of recommendations: TW, DC, HS. Data collection: TW, AE. Laboratory measurements: JK, KP. Data analysis: TW, AE, WEH, JMB, HMS. Review of the manuscript: All authors.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}